Targeting metalloenzymes for therapeutic intervention
AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases
VK Raker, C Becker, K Steinbrink - Frontiers in immunology, 2016 - frontiersin.org
Nucleotide signaling molecules contribute to the regulation of cellular pathways. In the
immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent …
immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent …
Clinical and molecular genetics of the phosphodiesterases (PDEs)
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …
Advances in the development of phosphodiesterase-4 inhibitors
T Peng, B Qi, J He, H Ke, J Shi - Journal of Medicinal Chemistry, 2020 - ACS Publications
Cyclic nucleotide phosphodiesterase 4 (PDE4) specifically hydrolyzes cyclic adenosine
monophosphate (cAMP) and plays vital roles in biological processes such as cancer …
monophosphate (cAMP) and plays vital roles in biological processes such as cancer …
Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases
M Wittmann, PS Helliwell - Dermatology and therapy, 2013 - Springer
Agents which increase intracellular cyclic adenosine monophosphate (cAMP) may have an
antagonistic effect on pro-inflammatory molecule production so that inhibitors of the cAMP …
antagonistic effect on pro-inflammatory molecule production so that inhibitors of the cAMP …
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
F Omar, JE Findlay, G Carfray… - Proceedings of the …, 2019 - National Acad Sciences
Cyclic AMP (cAMP) phosphodiesterase-4 (PDE4) enzymes degrade cAMP and underpin the
compartmentalization of cAMP signaling through their targeting to particular protein …
compartmentalization of cAMP signaling through their targeting to particular protein …
cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases
A Martinez, C Gil - Expert opinion on therapeutic patents, 2014 - Taylor & Francis
Introduction: PDEs are key enzymes in the adenosine and guanosine cyclic nucleotides
(cAMP and cGMP) signaling cascade. Their inhibition increases cyclic nucleotide levels …
(cAMP and cGMP) signaling cascade. Their inhibition increases cyclic nucleotide levels …
JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease
Objective To provide an overview of janus kinase (JAK), chemoattractant receptor
homologous molecule expressed on TH 2 cells (CRTH2), and phosphodiesterase 4 (PDE4) …
homologous molecule expressed on TH 2 cells (CRTH2), and phosphodiesterase 4 (PDE4) …
PDE4 inhibition and inflammatory bowel disease: a novel therapeutic avenue
M Spadaccini, S D'Alessio, L Peyrin-Biroulet… - International Journal of …, 2017 - mdpi.com
Background. In the last few decades, a better knowledge of the inflammatory pathways
involved in the pathogenesis of Inflammatory Bowel Disease (IBD) has promoted biological …
involved in the pathogenesis of Inflammatory Bowel Disease (IBD) has promoted biological …
Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors
M Perez-Aso, MC Montesinos, A Mediero… - Arthritis research & …, 2015 - Springer
Introduction This work was undertaken to delineate intracellular signaling pathways for the
PDE4 inhibitor apremilast and to examine interactions between apremilast, methotrexate …
PDE4 inhibitor apremilast and to examine interactions between apremilast, methotrexate …